Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07060898 · ClinicalTrials.gov registry record · NA

Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes

A NA study of Aging and Cognitive Decline, sponsored by Amazentis.

Active
Registry status
NA
Development phase
650
Enrollment target
1
Study location

NCT07060898 is a NA study of Aging and Cognitive Decline that is active but no longer recruiting, run by Amazentis. The registered enrollment target is 650 participants, below the 2,192-participant average among 262 other Aging trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07060898, a NA study of Aging and Cognitive Decline, is active but no longer recruiting, sponsored by Amazentis.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
650 participants
Enrollment target
1
Study location

Study Summary

This is a parallel group, randomized, double-blind, placebo-controlled clinical study assessing the safety and effects of a novel nutritional product on self-reported cognitive function and health in adults that reside in the USA. Participants will take their assigned study product (active or placebo) for 8 weeks and answer validated electronic surveys assessing cognitive function delivered to them through a text message (SMS) link or through email.

Interventions

  • DIETARY_SUPPLEMENT Active Product
  • DIETARY_SUPPLEMENT Placebo Product

Study Locations (1)

California

  • Radicle Science, Inc Office - Encinitas

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2025-07-29
Est. Completion 2026-11-20
Phase NA

Sponsor

Amazentis

5 total trials

What the Registry Record Tells You About NCT07060898

The ClinicalTrials.gov registry entry for NCT07060898 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,192-participant average among 262 other Aging trials with a reported enrollment target (70% lower). The listed sponsor is Amazentis, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Active Product is the first listed.

NCT07060898 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07060898 about?

NCT07060898 is a clinical study titled "Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes". This is a parallel group, randomized, double-blind, placebo-controlled clinical study assessing the safety and effects of a novel nutritional product on self-reported cognitive function and health in adults that reside in the USA. Participants will take their assigned study product (active or placeb...

What is the current status of trial NCT07060898?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 650 participants. The study started on 2025-07-29. Estimated completion is 2026-11-20.

What conditions does trial NCT07060898 study?

This clinical trial studies the following conditions: Aging, Cognitive Decline, Cognitive Function, Brain Fog.

What interventions are being tested in trial NCT07060898?

The interventions under investigation include: Active Product (DIETARY_SUPPLEMENT), Placebo Product (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07060898?

This trial is sponsored by Amazentis, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07060898 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.